Association between calcium channel blockers and breast cancer: A meta-analysis of observational studies

Pharmacoepidemiology and Drug Safety

Volumn 23, Issue 7, 2014, Pages 711-718

  Chen, Qi ^a   Zhang, Qianwen ^b   Zhong, Fei ^a   Guo, Shiwei ^a,c   Jin, Zhichao ^a   Shi, Wentao ^a   Chen, Chen ^a   He, Jia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Eastern Hepatobiliary Surgery Hospital   (China)

Author keywords

Breast cancer; Calcium channel blockers; Meta analysis; Pharmacoepidemiology

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DELAYED RELEASE FORMULATION;

ARTICLE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; HUMAN; META ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUSTAINED DRUG RELEASE; BREAST NEOPLASMS; CHEMICALLY INDUCED; DELAYED RELEASE FORMULATION; FEMALE; METHODOLOGY; RISK; STATISTICAL MODEL;

BREAST NEOPLASMS; CALCIUM CHANNEL BLOCKERS; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MODELS, STATISTICAL; RESEARCH DESIGN; RISK;

EID: 84903816770     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3645     Document Type: Article

References (25)

1. Boyle P, Levin B. World cancer report 2008: IARC Press, International Agency for Research on Cancer, 2008.
2. Davis S, Mirick DK. Medication use and the risk of breast cancer. Eur J Epidemiol 2007; 22: 319-325.
3. Li CI, Daling JR, Tang MT, et al.. Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years. JAMA Int Med 2013; 173(17): 1629-1637.
4. Fitzpatrick AL, Daling JR, Furberg CD, et al.. Use of calcium channel blockers and breast carcinoma risk in postmenopausal women. Cancer 1997; 80: 1438-1447.
5. Largent JA, Bernstein L, Horn-Ross PL, et al.. Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control 2010; 21: 1615-1624.
6. Assimes TL, Elstein E, Langleben A, et al.. Long-term use of antihypertensive drugs and risk of cancer. Pharmacoepidemiol Drug Saf 2008; 17: 1039-1049.
7. Fryzek JP, Poulsen AH, Lipworth L, et al.. A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat 2006; 97: 231-236.
8. Gonzalez-Perez A, Ronquist G, Garcia Rodriguez LA. Breast cancer incidence and use of antihypertensive medication in women. Pharmacoepidemiol Drug Saf 2004; 13: 581-585.
9. Michels KB, Rosner BA, Walker AM, et al.. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study. Cancer 1998; 83: 2003-2007.
10. Pahor M, Guralnik JM, Ferrucci L, et al.. Calcium-channel blockade and incidence of cancer in aged populations. Lancet 1996; 348: 493-497.
11. Wells G, Shea B, O'connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 3rd Symposium on Systematic Reviews: Beyond the Basics, 2000; 3-5.
12. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9: 1-30.
13. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998; 280: 1690-1691.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
15. Egger M, Davey Smith G, Schneider M, et al.. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 629-634.
16. Taylor S, Tweedie R. Practical estimates of the effect of publication bias in meta-analysis. Australas Epidemiol 1998; 5: 14-17.
17. Saltzman BS, Weiss NS, Sieh W, et al.. Use of antihypertensive medications and breast cancer risk. Cancer Causes Control 2013; 24: 365-371.
18. Li CI, Malone KE, Weiss NS, et al.. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79years. Cancer 2003; 98: 1504-1513.
19. Rosenberg L, Rao RS, Palmer JR, et al.. Calcium channel blockers and the risk of cancer. JAMA 1998; 279: 1000-1004.
20. Black N. Why we need observational studies to evaluate the effectiveness of health care. Br Med J 1996; 312: 1215.
21. Coogan PF. Calcium-channel blockers and breast cancer: a hypothesis revived. JAMA Int Med 2013; 173(17): 1637-1638.
22. Mann C. Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J 2003; 20: 54-60.
23. Raudys SJ, Jain AK. Small sample size effects in statistical pattern recognition: recommendations for practitioners. IEEE Trans Pattern Anal Mach Intell 1991; 13: 252-264.
24. Benjamini Y. Simultaneous and selective inference: current successes and future challenges. Biom J 2010; 52: 708-721.
25. Mason RP. Calcium channel blockers, apoptosis and cancer: is there a biologic relationship? J Am Coll Cardiol 1999; 34: 1857-1866.